Pharmaceutical compositions comprising anti-miRNA antisense oligonucleotides

Details for Australian Patent Application No. 2007234192 (hide)

Owner Santaris Pharma A/S

Inventors Kauppinen, Sakari; Kearney, Phil; Elmen, Joacim

Agent FB Rice

Pub. Number AU-A-2007234192

PCT Pub. Number WO2007/112754

Priority PA 2006 00615 01.05.06 DK; 60/838,710 18.08.06 US; PA 2006 01401 30.10.06 DK; PA 2006 00478 03.04.06 DK; 60/796,813 01.05.06 US; 60/788,995 03.04.06 US

Filing date 30 March 2007

Wipo publication date 11 October 2007

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 35/00 (2006.01) Antineoplastic agents

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

23 October 2008 PCT application entered the National Phase

  PCT publication WO2007/112754 Priority application(s): WO2007/112754

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007234195-A process for concentration of a polypeptide

2007234191-Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides